ClinicalTrials.gov
ClinicalTrials.gov Menu

Anterior Wedge in Patients With Osteoarthritis Hip

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03393923
Recruitment Status : Recruiting
First Posted : January 9, 2018
Last Update Posted : January 9, 2018
Sponsor:
Information provided by (Responsible Party):
Claudio Cazarini Junior, Faculdade de Ciências Médicas da Santa Casa de São Paulo

Brief Summary:
Ostearthritis is a great source of pain. In symptomatic hip the pain can lead the major disability and poor quality of life. Understand the musculoskeletal factores can lead to a better clinical management. The muscle strenghening of posterolateral complexo of hip is a important consideration. General Objective: Perform a Kinetic analysis 2D using na anterior wedge. Specific objective: Analyze the influence of posterolateral hip complex. Controlled clinical trial, composed by 30 individuals with and without osteoarthritis of hip e will be used a tools; Analogic Visual Scale, manual dynamometry to analyze force and kinetic analyze of gait through of Myovídeo analysis software.

Condition or disease Intervention/treatment Phase
Gait, Frontal Other: Application of the anterior wedge Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Effect of Anterior Wedge Use in Patients With Osteoarthritis Hip
Actual Study Start Date : July 10, 2017
Actual Primary Completion Date : January 1, 2018
Estimated Study Completion Date : December 10, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoarthritis

Arm Intervention/treatment
No Intervention: Control Group
Patient will undergo gait analysis
Experimental: Experimental group
Patient will undergo gait analysis with use of anterior wedge
Other: Application of the anterior wedge
Application of anterior wedge in tennis




Primary Outcome Measures :
  1. Inproved performance of the gluteus maximus [ Time Frame: 24 hours ]
    Extent moment will be assessed by gait analysis



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Sedentary individuals
  • Both genders
  • Age equal to or greather than 50 years
  • Diagnosis of osteoarthritis level II and III

Exclusion Criteria:

  • fractures
  • Neuromuscular diseases
  • Other diseases of hip

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03393923


Contacts
Contact: Flávia M Nakatake 5511991004148 flavianakatake@gmail.com

Locations
Brazil
Flávia Nakatake Recruiting
São Paulo, Brazil, 03918000
Contact: Flávia M Nakatake    5511991004148    flavianakatake@gmail.com   
Sponsors and Collaborators
Faculdade de Ciências Médicas da Santa Casa de São Paulo

Responsible Party: Claudio Cazarini Junior, Claudio Cazarini Júnior, Faculdade de Ciências Médicas da Santa Casa de São Paulo
ClinicalTrials.gov Identifier: NCT03393923     History of Changes
Other Study ID Numbers: 1112131232234
First Posted: January 9, 2018    Key Record Dates
Last Update Posted: January 9, 2018
Last Verified: January 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Gait Disorders, Neurologic
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms